# Johnson & Johnson (JNJ) — Q4-2016 Earnings Results

**Report date:** 2017-01-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.58 | N/A | +1.54% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings performance, highlighting their commitment to innovation. They emphasized the importance of adapting to market demands.

**Key quotes:**

> We are pleased with our performance this quarter.

> Our focus remains on innovation and meeting consumer needs.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson exceeded expectations on EPS, which is a positive sign for the company. However, the lack of revenue data and guidance may leave investors cautious. The stock reaction is not available, indicating uncertainty in market response.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2016_